Susan E. Stuber

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial

Russell E. Ware, Barry R. Davis, William H. Schultz et al. · The Lancet · 2015 · 496 citations · Full text

Pediatric Hematology, Hematology, Neurological Monitoring +10

Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa

Léon Tshilolo, George Tomlinson, Thomas N. Williams et al. · New England Journal of Medicine · 2018 · 354 citations · Full text

Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub‐Saharan Africa: Rationale and Design of the REACH Trial

Patrick T. McGann, Léon Tshilolo, Brígida Santos et al. · Pediatric Blood & Cancer · 2015 · 64 citations · Full text

Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub‐Saharan Africa

Patrick T. McGann, Thomas N. Williams, Peter Olupot‐Olupot et al. · American Journal of Hematology · 2018 · 37 citations · Full text

Hydroxyurea Treatment, Immunohematology, Population Health Sciences +23

Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial

Emmanuela E. Ambrose, Teresa Latham, Primrose Songoro et al. · The Lancet Haematology · 2023 · 31 citations · Full text

Thrombosis, Sickle Cell Anaemia, Ischemic Stroke +11